High viscosity embolizing compositions
First Claim
Patent Images
1. A method for enhancing the formation of a solid, non-migratory coherent mass at a selected vascular site of a mammal which method comprises:
- (a) placing a delivery device having an ejection port at a selected vascular site in a mammal;
(b) delivering through the ejection port of the delivery device a composition capable of embolizing an aneurysm at a vascular site comprising;
a. a biocompatible polymer at a concentration of from about 12 to about 50 weight percent based on the total weight of the composition;
b. a biocompatible contrast agent wherein a sufficient amount of said contrast agent is employed in said composition to effect visualization in vivo; and
c. a biocompatible solvent which solubilizes said biocompatible polymer;
wherein sufficient amounts of said polymer are employed in said composition such that upon delivery to said vascular site a polymer precipitate forms which embolizes said vascular site;
and further wherein the biocompatible polymer has a molecular weight and/or concentration sufficient to impart to the composition a viscosity of at least about 150 cSt at 40°
C.
6 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are novel compositions for embolizing blood vessels which are particularly suited for treating vascular lesions via catheter deliver.
51 Citations
18 Claims
-
1. A method for enhancing the formation of a solid, non-migratory coherent mass at a selected vascular site of a mammal which method comprises:
-
(a) placing a delivery device having an ejection port at a selected vascular site in a mammal;
(b) delivering through the ejection port of the delivery device a composition capable of embolizing an aneurysm at a vascular site comprising;
a. a biocompatible polymer at a concentration of from about 12 to about 50 weight percent based on the total weight of the composition;
b. a biocompatible contrast agent wherein a sufficient amount of said contrast agent is employed in said composition to effect visualization in vivo; and
c. a biocompatible solvent which solubilizes said biocompatible polymer;
wherein sufficient amounts of said polymer are employed in said composition such that upon delivery to said vascular site a polymer precipitate forms which embolizes said vascular site;
and further wherein the biocompatible polymer has a molecular weight and/or concentration sufficient to impart to the composition a viscosity of at least about 150 cSt at 40°
C. - View Dependent Claims (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
-
-
2. A method for enhancing the formation of a solid, non-migratory coherent mass at a selected vascular site of a mammal which method comprises:
-
(a) placing a delivery device having an ejection port at a selected vascular site in a mammal;
(b) delivering through the ejection port of the delivery device a composition capable of embolizing an aneurysm at a vascular site comprising;
a) a biocompatible polymer at a concentration of from about 12 to about 50 weight percent;
b) a biocompatible contrast agent at a concentration of from about 10 to about 40 weight percent; and
c) a biocompatible solvent from about 10 to 88 weight percent;
wherein the weight percents of the biocompatible polymer, contrast agent, and biocompatible solvent are based on the total weight of the composition;
and further wherein the biocompatible polymer has a molecular weight and/or concentration sufficient to impart to the composition a viscosity of at least about 150 cSt at 40°
C.
-
Specification